CEVR
tuftscevr.bsky.social
CEVR
@tuftscevr.bsky.social
Center for the Evaluation of Value and Risk in Health at Medical Center. Posts and reposts are not endorsements.

https://cevr.tuftsmedicalcenter.org/
Going to AMCP 2025? Come see presentations by @mollytoba.bsky.social, Daniel Enright, and Angela Lin of CEVR's SPEC Team!

#AMCPNexus
October 13, 2025 at 2:01 PM
Meet Hao-Hsin (Taylor) Huang, MS, today’s featured #CEARegistry Summer Fellow. Taylor is pursuing her PhD in Pharmacy Systems, Outcomes, and Policy at the University of Illinois, Chicago.

Our thanks to the @moorefound.bsky.social for funding the CEA Registry Fellowship program!
July 28, 2025 at 2:42 PM
CEVR Summer Fellow Spotlight: we’re thrilled to have Rosemond Amamoo, MD, MPH as a #CEARegistry Summer Fellow! Rosemond is pursuing her PhD in Health and Pharmaceutical Outcomes at @uarizona.bsky.social.

Our thanks to the @moorefound.bsky.social for funding the CEA Registry Fellowship program!
July 21, 2025 at 3:57 PM
Today’s #CEARegistry Summer Fellow is Pooja Gokhale, PharmD. Pooja is pursuing her PhD in Pharmaceutical Health Services, Outcomes, and Policy at @universityofga.bsky.social.

Our thanks to @moorefound.bsky.social for funding the CEA Registry Fellowship program!‬‬
July 17, 2025 at 4:57 PM
Larry Mose, MSc is today’s #CEARegistry Summer fellow. Larry earned his MSc from @york.ac.uk and hopes to work in the field of #HEOR.

Our thanks to the @moorefound.bsky.social ‬for funding the CEA Registry Fellowship program!‬‬
July 14, 2025 at 5:13 PM
Meet Fengdi Zhang, MPH, today's featured #CEARegistry Summer Fellow. Fengdi is pursuing her PhD in Pharmaceutical Health Services Research at @univofmaryland.bsky.social

Our thanks to the @moorefound.bsky.social for funding the CEA Registry Fellowship program!
June 30, 2025 at 3:46 PM
Meet Hanxuan (Astrid) Yu, MEd, today’s #CEARegistry summer fellow. Astrid is working toward her PhD at @hsph.harvard.edu

Our thanks to @moorefound.bsky.social for funding the CEA Registry Fellowship program!‬
June 23, 2025 at 4:10 PM
The #IRA #Medicare Part D benefit redesign may significantly lower OOP drug spending for beneficiaries with #dementia and multiple comorbidities. Read the new CEVR study in Value in Health for more details.

authors.elsevier.com/a/1ke483vkP0...
March 4, 2025 at 5:28 PM